Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sinemet Plus 25mg/100mg tablets
0409010N0BBACAB
|
Sinemet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 38,820 |
|
Half Sinemet CR 25mg/100mg tablets
0409010N0BBAFAG
|
Sinemet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 36,654 |
|
Sinemet 12.5mg/50mg tablets
0409010N0BBAGAD
|
Sinemet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 33,501 |
|
Sinemet CR 50mg/200mg tablets
0409010N0BBAEAE
|
Sinemet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 14,844 |
|
Sinemet 25mg/250mg tablets
0409010N0BBABAC
|
Sinemet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 2,109 |
|
Sinemet 10mg/100mg tablets
0409010N0BBAAAA
|
Sinemet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 673 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.